Patents by Inventor Ian Alexander

Ian Alexander has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SINGLE-USE EXPANDABLE LIQUID CONTAINER AND BLANK
    Publication number: 20190358108
    Abstract: The present invention relates to a single-use container (200) manufactured from sheet material, the single-use container comprising: a base (206), wherein the base is flat and forms a surface on which the single-use container can stand,—a front wall (201), a right wall (202), a left wall (203) and a rear wall (204) which extend upward from the base, wherein the front wall and the rear wall are convex, and wherein the right wall and left wall are concave, an upper end (207) which connects the front wall, right wall, left wall and rear wall.
    Type: Application
    Filed: January 18, 2018
    Publication date: November 28, 2019
    Inventors: David COCKS, Ian Alexander WEBB
  • Papaver somniferum cytochrome P450
    Patent number: 10385354
    Abstract: This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: August 20, 2019
    Assignee: Sun Pharmaceutical Industries (Australia) Pty Ltd
    Inventors: Thilo Hans Winzer, Tracy Carol Walker, Ian Alexander Graham
  • COMPOSITIONS AND METHODS FOR BIOFILM REMOVAL
    Publication number: 20190223434
    Abstract: Methods for removing biofilm or preventing biofilm formation from surfaces are provided, the methods comprising applying compositions to the surface to remove the biofilm or inhibit its formation, the compositions comprising polymers derived from alkyl polyglucosides functionalized with cationic side chains.
    Type: Application
    Filed: January 18, 2019
    Publication date: July 25, 2019
    Inventors: Ramakrishnan Balasubramanian, Ian Alexander Richardson, Duy T. Nguyen
  • PLANT CYTOCHROME P450
    Publication number: 20190161764
    Abstract: This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.
    Type: Application
    Filed: February 4, 2019
    Publication date: May 30, 2019
    Applicant: Sun Pharmaceutical Industries (Australia) Pty Ltd
    Inventors: Thilo Hans Winzer, Tracy Carol Walker, Ian Alexander Graham
  • ADENO-ASSOCIATED VIRUS POLYNUCLEOTIDES, POLYPEPTIDES AND VIRIONS
    Publication number: 20190135870
    Abstract: Polypeptides are encoded by an adeno-associated virus (AAV)-derived endogenous viral element (mAAV-EVE1) found within the germline of numerous closely-related marsupial species. Nucleic acid molecules encode the polypeptides. Vectors can include the nucleic acid molecules, and recombinant AAV virions can include the polypeptides. A chimeric capsid protein can also include an MAAV-EVE1 polypeptide.
    Type: Application
    Filed: May 3, 2017
    Publication date: May 9, 2019
    Applicants: Children's Medical Research Institute, The Sydney Children's Hospitals Network (Randwick and Westmead) (incorporating The Royal Alexanndra, The United States of America, as represented by the Secretary, Department of Health and Human
    Inventors: Claus Hallwirth, Ian Alexander, Richard Smith, Robert Kotin
  • SUBSTITUTED 3-HALOALLYLAMINE INHIBITORS OF SSAO AND USES THEREOF
    Publication number: 20190071396
    Abstract: The present invention is related to the preparation and pharmaceutical use of substituted 3-haloallylamine derivatives as SSAO/VAP-1 inhibitors having the structure of Formula I, as defined in the specification: The invention also relates to methods of using compounds of Formula I, or pharmaceutically acceptable salt or derivatives thereof, for the treatment of a variety of indications, e.g., inflammatory diseases, ocular diseases, fibrotic diseases, diabetes-induced diseases and cancer.
    Type: Application
    Filed: November 1, 2018
    Publication date: March 7, 2019
    Inventors: Mandar Deodhar, Alison Dorothy Findlay, Jonathan Stuart Foot, Wolfgang Jarolimek, Ian Alexander Mcdonald, Alan Duncan Robertson, Craig Ivan Turner
  • Turboprop engine with compressor turbine shroud
    Patent number: 10196975
    Abstract: A method of isolating a turbine shroud from propeller loads in an engine having an outer case with a mount defining a mount plane and an attachment location within the mount plane, the mount configured for attachment of the engine to an aircraft at the attachment location to transfer the propeller loads. The shaft of the engine is supported with a portion of the outer case extending from the mount and defining a load path for the propeller loads. The turbine support case is attached to extend free of the load path, by attaching the turbine support case to the outer case only through a connection along the plane, the connection defining a pivot point allowing a limited relative pivoting motion around the pivot point between the turbine support case and the mount. The turbine shroud is located by directly connecting it to the turbine support case.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: February 5, 2019
    Assignee: PRATT & WHITNEY CANADA CORP.
    Inventor: Ian Alexander MacFarlane
  • Substituted 3-haloallylamine inhibitors of SSAO and uses thereof
    Patent number: 10160723
    Abstract: The present invention is related to the preparation and pharmaceutical use of substituted 3-haloallylamine derivatives as SSAO/VAP-1 inhibitors having the structure of Formula I, as defined in the specification: The invention also relates to methods of using compounds of Formula I, or pharmaceutically acceptable salt or derivatives thereof, for the treatment of a variety of indications, e.g., inflammatory diseases, ocular diseases, fibrotic diseases, diabetes-induced diseases and cancer.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: December 25, 2018
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Mandar Deodhar, Alison Dorothy Findlay, Jonathan Stuart Foot, Wolfgang Jarolimek, Ian Alexander Mcdonald, Alan Duncan Robertson, Craig Ivan Turner
  • REALTIME SCHEDULE MANAGEMENT INTERFACE
    Publication number: 20180285821
    Abstract: Embodiments are directed towards generating and managing schedules. In at least one of the various embodiments, these schedules may be configured to schedule team members, rotating which team member is active (“on-call”). In at least one of the various embodiments, these may be employed to determine which resource is responsible to respond and/or resolve incidents that may be reported and/or detected. In at least one of the various embodiments, if a team member is determined to be the on-call or responsible team member, the notification engine may determine the methods for notify the responsible of the incidents. Schedules previews may be updated in real-time as the schedule is edited.
    Type: Application
    Filed: November 14, 2017
    Publication date: October 4, 2018
    Inventors: Dan Alexandru Solomon, John Gary Ryan Laban, Ian Alexander Enders, Ali Basiri, Andrew Gregory Miklas
  • WEAR INDICATOR FOR GAS TURBINE ENGINE
    Publication number: 20180252117
    Abstract: In combination a wear indicator and a component of a gas turbine engine is provided. The wear indicator is secured to a surface of the component of the gas turbine engine. The wear indicator comprising: a first side delaminates when impacted by a blade of the gas turbine engine; a second side parallel to the first side, the second side being secured to a surface of the component of the gas turbine engine; a mid-section interposed between the first side and the second side; and a reference dimension remains constant when the first side delaminates.
    Type: Application
    Filed: March 6, 2017
    Publication date: September 6, 2018
    Inventors: Eli Cole Warren, Darren M. Wind, Ian Alexander Fielder Agoos
  • PROMOTERS FOR EXPRESSION OF HETEROLOGOUS GENES
    Publication number: 20180142260
    Abstract: The present disclosure relates generally to promoters derived from the AAV anti-sense strand, their use in the expression of one or more heterologous coding sequences, and isolated polynucleotides, vectors and recombinant viruses comprising the promoters. The present disclosure also relates to enhancers derived from the AAV anti-sense strand, their use in increasing the expression of one or more heterologous coding sequences, and isolated polynucleotides, vectors and recombinant viruses comprising the enhancers.
    Type: Application
    Filed: May 4, 2016
    Publication date: May 24, 2018
    Inventors: Grant Logan, Ian Alexander
  • CARTRIDGE FOR THE PREPARATION OF BEVERAGES
    Publication number: 20180093820
    Abstract: A cartridge for preparation of a beverage is provided which is sealed prior to use and contains one or more beverage ingredients. The cartridge comprises: a body defining a beverage ingredient chamber containing the one or more beverage ingredients; a first filter defining an exit from the beverage ingredient chamber; a second filter downstream of, and spaced apart from, the first filter; and a flow constriction downstream of the second filter, such that in use beverage produced from the one or more beverage ingredients passes, in order, through the first filter, the second filter and the flow constriction.
    Type: Application
    Filed: November 27, 2017
    Publication date: April 5, 2018
    Inventors: Tulay Massey, John Melrose, Tony Saunders, Simon Carr, Ian Alexander James Radcliffe, Willem Paul Beeker, Stuart James Curtis
  • SUBSTITUTED 3-HALOALLYLAMINE INHIBITORS OF SSAO AND USES THEREOF
    Publication number: 20180086698
    Abstract: The present invention is related to the preparation and pharmaceutical use of substituted 3-haloallylamine derivatives as SSAO/VAP-1 inhibitors having the structure of Formula I, as defined in the specification: The invention also relates to methods of using compounds of Formula I, or pharmaceutically acceptable salt or derivatives thereof, for the treatment of a variety of indications, e.g., inflammatory diseases, ocular diseases, fibrotic diseases, diabetes-induced diseases and cancer.
    Type: Application
    Filed: October 5, 2017
    Publication date: March 29, 2018
    Inventors: Mandar Deodhar, Alison Dorothy Findlay, Jonathan Stuart Foot, Wolfgang Jarolimek, Ian Alexander Mcdonald, Alan Duncan Robertson, Craig Ivan Turner
  • Biosynthesis of opiate alkaloids
    Patent number: 9862979
    Abstract: The disclosure relates to a nucleic acid molecule isolated from a Papaver somniferum cultivar that produces the opiate alkaloid noscapine which comprises 10 genes involved in the biosynthesis of opiate alkaloids.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: January 9, 2018
    Assignee: Sun Pharmaceutical Industries (Australia) Pty Ltd
    Inventors: Thilo Winzer, Ian Alexander Graham, Tracy Carol Walker
  • PLANT CYTOCHROME P450
    Publication number: 20170369896
    Abstract: This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.
    Type: Application
    Filed: March 27, 2017
    Publication date: December 28, 2017
    Applicant: Sun Pharmaceutical Industries (Australia) Pty Ltd
    Inventors: Thilo Hans Winzer, Tracy Carol Walker, Ian Alexander Graham
  • Realtime schedule management interface
    Patent number: 9830578
    Abstract: Embodiments are directed towards generating and managing schedules. In at least one of the various embodiments, these schedules may be configured to schedule team members, rotating which team member is active (“on-call”). In at least one of the various embodiments, these may be employed to determine which resource is responsible to respond and/or resolve incidents that may be reported and/or detected. In at least one of the various embodiments, if a team member is determined to be the on-call or responsible team member, the notification engine may determine the methods for notify the responsible of the incidents. Schedules previews may be updated in real-time as the schedule is edited.
    Type: Grant
    Filed: May 30, 2014
    Date of Patent: November 28, 2017
    Assignee: PagerDuty, Inc.
    Inventors: Dan Alexandru Solomon, John Gary Ryan Laban, Ian Alexander Enders, Ali Basiri, Andrew Gregory Miklas
  • Substituted 3-haloallylamine inhibitors of SSAO and uses thereof
    Patent number: 9815782
    Abstract: The present invention is related to the preparation and pharmaceutical use of substituted 3-haloallylamine derivatives as SSAO/VAP-1 inhibitors having the structure of Formula I, as defined in the specification: The invention also relates to methods of using compounds of Formula I, or pharmaceutically acceptable salt or derivatives thereof, for the treatment of a variety of indications, e.g., inflammatory diseases, ocular diseases, fibrotic diseases, diabetes-induced diseases and cancer.
    Type: Grant
    Filed: February 26, 2016
    Date of Patent: November 14, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Mandar Deodhar, Alison Dorothy Findlay, Jonathan Stuart Foot, Wolfgang Jarolimek, Ian Alexander Mcdonald, Alan Duncan Robertson, Craig Ivan Turner
  • Plant cytochrome P450
    Patent number: 9725732
    Abstract: This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.
    Type: Grant
    Filed: October 15, 2015
    Date of Patent: August 8, 2017
    Assignee: Sun Pharmaceutical Industries (Australia) Pty Ltd
    Inventors: Thilo Winzer, Tracy Carol Walker, Ian Alexander Graham
  • Stable Gene Transfer to Proliferating Cells
    Publication number: 20170216456
    Abstract: Provided herein are methods for facilitating or inducing stable transgene integration and expression in a proliferating cell, comprising administering to the cell (i) a recombinant AAV (rAAV) vector comprising the transgene flanked by transposon-derived inverted terminal repeat sequences, which sequences are in turn flanked by AAV-derived inverted terminal repeat regions, and (ii) a source of a transposase that recognises said transposon-derived inverted terminal repeat sequences and directs the genomic integration of the transgene into the genome of the proliferating cell. Also provided are methods and transgene delivery systems for the treatment or prevention of diseases affecting, associated with or characterised by proliferating cells, including paediatric liver diseases, bone marrow diseases and cancer.
    Type: Application
    Filed: March 23, 2015
    Publication date: August 3, 2017
    Inventors: Ian Alexander, Sharon Cunningham, Andras Nagy
  • Ice cream package
    Patent number: D813050
    Type: Grant
    Filed: December 24, 2015
    Date of Patent: March 20, 2018
    Assignee: Conopco, Inc.
    Inventors: Kevin Stuart Blake, James Peter Dougan, James Giles, Thomas Le Plastrier Maurice, Ian Alexander MacKay